Nuclear Medicine: Page 21

Isotopia and CPDC ships first doses of Lu-177

By AuntMinnie.com staff writers

Isotopia Molecular Imaging and the Center for Probe Development and Commercialization (CPDC) said the first doses of no-carrier-added lutetium-177 (Lu-177) have been shipped to clients in North America.

June 8, 2022

Ukrainian radiologist writes on effect of war

By Will Morton

A radiologist practicing in a nuclear medicine clinic in the Ukrainian city of Kyiv has written about his experience caring for patients in the war-torn city. The letter was published in the June issue of the Journal of Nuclear Medicine.

June 8, 2022

JNM issues supplement on neurodegeneration imaging

By AuntMinnie.com staff writers

The Journal of Nuclear Medicine (JNM) recently issued a supplement that provides an up-to-date overview on molecular imaging in neurodegeneration, as well as a discussion on the future of the field.

June 2, 2022

Best practices could help AI deployment in nuclear medicine

By Will Morton

Nuclear medicine imaging lacks a rigorous strategy for evaluating artificial intelligence (AI) algorithms developed for clinical use, say an international group of experts. To that end, they recently offered a set of best practices that they say could help transfer research into the field.

May 30, 2022

ImaginAb inks deal with pharma developer in China

By AuntMinnie.com staff writers

Immuno-PET developer ImaginAb has signed an exclusive license with DongCheng Pharmaceutical Group to commercialize cancer imaging radiotracers across China.

May 24, 2022

Kubtec to acquire Oncovision's GammaPro system

By AuntMinnie.com staff writers

Digital x-ray firm Kubtec has signed a deal to acquire the GammaPro sentinel lymph node probe from Spanish medical technology developer Oncovision.

May 15, 2022

Monrol to supply Telix with Lu-177 for renal cancer trial

By AuntMinnie.com staff writers

Eczacıbaşı-Monrol Nuclear Products will provide lutetium-177 (Lu-177) to Telix Pharmaceuticals Limited for a phase II clinical trial of its Starlite 2 renal cancer therapy medication TLX250.

May 10, 2022

Novartis suspends shipments of Lu-177 ligand therapy agents

By AuntMinnie.com staff writers

Novartis has temporarily suspended supply of its two therapeutic radiopharmaceuticals based on lutetium-177 (Lu-177) ligands due to "quality issues identified in its manufacturing processes," the company said in a May 5 statement.

May 5, 2022

Use of V/Q scans dropped during COVID-19 pandemic

By Will Morton

Nuclear medicine ventilation/perfusion scintigraphy (V/Q) dropped significantly during the COVID-19 pandemic, as hospitals took up new protocols to reduce the chances of infections, according to an abstract presented at the American Roentgen Ray Society meeting in New Orleans.

May 2, 2022

Sofie to open expanded radiopharm manufacturing center

By AuntMinnie.com staff writers

Sofie plans to expand its existing radiopharmaceutical contract manufacturing facility in Totowa, NJ, from 10,000 square feet to 20,000 square feet.

May 1, 2022

Qsam doses first patient in Cyclosam clinical trial

By AuntMinnie.com staff writers

Qsam Biosciences said the first patient has begun treatment in the company's clinical trial evaluating samarium-153-DOTMP (CycloSam) for the treatment of bone cancer and related diseases.

April 28, 2022

Spectrum rolls out attenuation correction software

By AuntMinnie.com staff writers

Spectrum Dynamics said it has deployed its TruCorr attenuation correction software for its D-SPECT Series digital gamma camera across the U.S., Europe, and Asia.

April 24, 2022

Previous Page

Page 21 of 438

Next Page